Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The peptide may offer greatest value as an adjunctive therapy combined with conventional hair loss treatments or as a maintenance therapy following more aggressive interventions
Evaluated in controlled preclinical settings for cellular senescence marker expression
The FDA approved sermorelin (Geref, Serono) under NDA 19-559 for GH deficiency in children
It appears to bind to p53 and thereby may prevent apoptotic death of the senescent cells
It is a nonapeptide associated with the regulation of sleep-wake cycles and neuroendocrine function
It has passed the GMP certification of China, the United States, South Korea, and Mexico, and has passed the US FDA review with "0 defects", demonstrating the international quality management level
US$ 23.96
US$ 26.45
US$ 19.98
US$ 24.17
US$ 26.65
US$ 21.23
US$ 25.86
